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Background: Bifidobacteria is one of the major gut commensal groups found in infants. Their colonization is
commonly associated with beneficial effects to the host through mechanisms like niche occupation and nutrient
competition against pathogenic bacteria. Iron is an essential element necessary for most microorganisms, including
bifidobacteria and efficient competition for this micronutrient is linked to proliferation and persistence. For this
research we hypothesized that bifidobacteria in the gut of iron deficient infants can efficiently sequester iron. The
aim of the present study was to isolate bifidobacteria in fecal samples of iron deficient Kenyan infants and to
characterize siderophore production and iron internalization capacity.
Results: Fifty-six bifidobacterial strains were isolated by streaking twenty-eight stool samples from Kenyan infants,
in enrichment media. To target strains with high iron sequestration mechanisms, a strong iron chelator 2,2-dipyridyl
was supplemented to the agar media. Bifidobacterial isolates were first identified to species level by 16S rRNA
sequencing, yielding B. bifidum (19 isolates), B. longum (15), B. breve (11), B. kashiwanohense (7), B. pseudolongum
(3) and B. pseudocatenulatum (1). While most isolated bifidobacterial species are commonly encountered in the
infantile gut, B. kashiwanohense was not frequently reported in infant feces. Thirty strains from culture collections
and 56 isolates were characterized for their siderophore production, tested by the CAS assay. Siderophore activity
ranged from 3 to 89% siderophore units, with 35 strains (41%) exhibiting high siderophore activity, and 31 (36%)
and 20 (23%) showing intermediate or low activity. The amount of internalized iron of 60 bifidobacteria strains
selected for their siderophore activity, was in a broad range from 8 to118 μM Fe. Four strains, B. pseudolongum
PV8-2, B. kashiwanohense PV20-2, B. bifidum PV28-2a and B. longum PV5-1 isolated from infant stool samples were
selected for both high siderophore activity and iron internalization.
Conclusions: A broad diversity of bifidobacteria were isolated in infant stools using iron limited conditions, with
some strains exhibiting high iron sequestration properties. The ability of bifidobacteria to efficiently utilize iron
sequestration mechanism such as siderophore production and iron internalization may confer an ecological
advantage and be the basis for enhanced competition against enteropathogens.
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Bifidobacteria represent one of the most predominant
groups of commensal bacteria residing in the human
and animal gastrointestinal tract [1]. Bifidobacterium
spp. are among the first anaerobes able to reach high
levels within the first week of life and generally represent
more than 40% of infant gut microbiota [2,3]. Different* Correspondence: christophe.lacroix@hest.ethz.ch
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article, unless otherwise stated.Bifidobacterium species are associated with a broad range
of beneficial effects on host’s health. Their colonization in
the gut is associated with modulation of the intestinal
microbiota composition and activity, immune-modulation
and attenuation of inflammatory symptoms [4,5]. Add-
itionally, mechanisms involved in host protection include
nutrient competition, competitive exclusion, direct antag-
onism by inhibitory substances and host-mediated effects
such as improved barrier function and altered immune
response [6,7]. Numerous studies have demonstrated the
efficacy against enteric pathogens of selected bifidobacterialed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Occurrence and isolate numbers of isolated
Bifidobacterium species in the infant stool samples (n = 28)
Distribution of bifidobacterial
species in infant fecal samples
No. isolates
obtained
n = 28 n = 56
B. bifidum 13 19
B. longum 8 15
B. breve 8 11
B. kashiwanohense 3 7
B. pseudolongum 1 3
B. pseudocatenulatum 1 1
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benefits is still often lacking [8]. Strain dependency is one
of the features that have been revealed while seeking for
new probiotic strains [9], thus the importance of selection
of suitable candidates through biochemical assays targeting
potential probiotic functions.
Iron is an essential micronutrient for most intestinal
commensal and pathogenic bacteria, except for Lactoba-
cillus [10]. Iron is involved in many essential metabolic
processes like cell proliferation, electron transport, and
is a cofactor for different enzymes [11]. For instance,
iron plays an important role in most pathogenic bacteria,
as iron sequestration mechanism have been associated to
cell replication and persistence and thus being involved in
pathogenesis [12]. However, iron is restricted in most
environments including the mammalian intestine [13].
The limited availability of iron in the host provides one
form of non-specific immune-defence that bacteria, for
instance, bacterial pathogens need to overcome in order
to grow and cause infection [14]. Therefore microor-
ganisms have evolved different acquisition systems like
import of iron from different sources and production of
siderophores to utilize, accumulate and sequester iron
[15]. Various physiological mechanisms such as low/high
affinity iron transport systems are employed by bacteria to
tightly control iron uptake, intracellular concentration
and storage, preventing toxic effects [16]. Iron starvation
signals the up-regulation of acquisition systems and as a
response many gram positive bacteria synthesize low
molecular weight iron chelating ligands, known as sidero-
phores, to compete for iron [17]. In contrast, iron excess
activates the expression of efflux pumps and ferritin like
proteins involved in iron accumulation [18,19].
Withholding iron has been identified as a major com-
petitive and defense mechanisms in many gram positive
and gram negative bacteria, because of its general limited
availability in different environments, such as the intestine
[20,21]. The concept of restricting iron to pathogens has
been coined as nutritional immunity [22,23] and is usually
associated with efficient iron sequestration systems. It has
been hypothesized that one of the beneficial actions of
health promoting bifidobacteria is to sequester iron, thus
making it less available to pathogens, hence representing
another form of nutritional immunity [24]. The ability of
bifidobacteria to outcompete by producing siderophores
and/or concentrating iron from the environment may
therefore provide a competitive advantage against compet-
ing microorganism by limiting the iron available in com-
plex ecosystems such as the gut microbiota. Thus,
bifidobacteria, may cause iron starvation of competing
microorganism; for instance, enteropathogens. However
to our knowledge, the ability to produce siderophores in
culture supernatant and to internalize iron of diverse
bifidobacteria species has never been investigated. Wehypothesized that bifidobacteria present in the gut of iron
deficient infants efficiently sequester iron. Therefore our
aim was to isolate Bifidobacterium strains from stool sam-
ples from iron deficient Kenyan infants and to investigate
their ability to produce siderophores as well as to seques-
ter iron in comparison to culture collection strains.Results
Isolation and genotypic identification
The bifidobacteria gene copy numbers (CN) was, assessed
in the twenty-eight stool samples of Kenyan infants by
qPCR targeting the xylulose-5-phosphate/fructose-6-
phosphatephosphoketolase gene (xfp) gene. The mean
bifidobacteria CN was log 9.8 SD +/− 0.4 copies per
gram feces, in the range from log 6.4 to log 10.4 copies
per gram feces sample. Twenty-eight baseline stool
samples from Kenyan infants were streaked in BRS,
MRS-cys, TPY and BSM agar supplemented with a strong
iron chelator 2,2-dipiridyl. A total of 208 strains were
isolated and analyzed by 16S rRNA gene sequencing for
identification. 16S rRNA partial sequences with a length
of 1100 to 1300 bp after quality trimming were aligned
for genotypic identification using BLAST, yielding 41%
Enterococcus spp. (94 isolates), 29% Bifidobacterium
spp. (56), 28% Lactobacillus spp. (54), 1% Weisella spp.
(2), 0.5% Streptoccocus spp. (1) and 0.5% Leuconostoc
spp. (1). Bifidobacterium 16S rRNA partial sequences
were assigned to six phylogenetic taxa: 34% B. bifidum
(19 isolates), 27% B. longum (15), 19% B. breve (11),
13% B. kashiwanohense (7), 5% B. pseudolongum (3),
2% B. pseudocatenulatum (1) (Table 1). B. bifidum was
most frequently isolated in BSM and Beerens agar,
while B. longum and B. breve were obtained from TPY
plates and B. kashiwanohense from TPY and BSM
plates. Bifidobacterium isolated on BSM agar represented
five species (5), compared to four species isolated on
Beerens, three on TPY and only one on MRS-cys (1) agar.
Three different bifidobacteria species were isolated from
each stool samples 3, 5, 8 and 11 (Table 2), while either
one or two bifidobacterial species were obtained from the
Table 2 Bifidobacterial population and species isolated from Kenyan infant stool samples (n = 28)
Feces sample Hb (g/dl) Total bacteria Bifidobacteria population Isolated species from different iron restricted media
1 10.1 11.6 9.7 B. breve BSM1-2
2 8.7 10.4 9.4 B. bifidum BSM2-1, B. bifidum BSM2-3, B. breve TPY2-1,
B. breve TPY2-3, B. breve TPY2-4
3 10.2 10.9 9.5 B. breve BSM3-1, B. longum TPY3-1, B. longum TPY3-2, B. pseudocatenulatum
BRS3-2, B. bifidum BRS-300
4 9.9 11.8 6.4 B. longum TPY4-1
5 9.6 11.3 8.9 B. longum PV5-1, B. bifidum BRS5-3, B. breve TPY5-1, B. breve TPY5-2
6 9.2 10.3 9.0 B. bifidum TPY6-2, B. bifidum MRSc6-292, B. bifidum MRSc6-312
7 8.6 10.8 9.5 No Bifidobacterium isolates obtained
8 8.1 11.7 10.0 B. pseudolongum PV8-2, B. pseudolongum BSM8-1, B. pseudolongum BSM8-3,
B. breve BSM8-4, B. bifidum BRS8-1, B. bifidum BRS8-2, B. bifidum BRS8-3,
B. longum TPY8-1, B. longum TPY8-2
9 9.9 11.1 9.5 No Bifidobacterium isolates obtained
10 9.8 11.2 9.9 B. breve TPY10-1, B. breve TPY10-2
11 9.5 12.1 10.1 B. kashiwanohense BSM11-1, B. kashiwanohense BSM11-4,
B. longum BSM11-5, B. kashiwanohense TPY11-1,
B. kashiwanohense BRS11-1, B. kashiwanohense TPY11-2
12 11.3 12.2 9.7 B. bifidum BSM12-2, B. longum TPY12-1
13 10.3 9.9 9.2 B. longum TPY13, B. longum TPY13-2, B. longum TPY13-3
14 10.4 10.6 9.4 No bifidobacteria isolate obtained
15 10.4 10.4 9.1 B. bifidum BSMd15, B. bifidum BSM15-2,
16 10.5 10.6 9.3 B. bifidum BRS16-1, B. breve TPY16-2
17 10.5 10.7 9.4 No Bifidobacterium isolates obtained
18 10.8 11.1 9.1 B. bifidum BSM18
19 10.8 10.5 8.9 No Bifidobacterium isolates obtained
20 11.1 10.7 9.0 B. kashiwanohense PV20-2
21 11.3 10.7 9.0 B. bifidum BRS21
22 11.4 10.1 8.9 No Bifidobacterium isolates obtained
23 11.8 11.7 10.4 No Bifidobacterium isolates obtained
24 11.8 11.7 10.2 No Bifidobacterium isolates obtained
25 NDA 10.4 9.3 B. kashiwanohense TPY25-1
26 NDA 11.1 9.0 B. bifidum BRS26-2 , B. longum TPY26-1
27 NDA 10.1 9.0 B. breve TPY27, B. bifidum BRS27-3
28 NDA 12.0 9.7 B. bifidum PV28-2a , B. bifidum BSM28-1, B. bifidum BSMd28-2
Bifidobacterial population is expressed as bifidobacterial log copies per gram feces. SD for bifidobacteria population among samples was +/− 0.35 and for total
bacteria SD +/− 0.56. NDA: No data available. Hb: Hemoglobin level (g/dL).
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found in three fecal samples 11, 20 and 25 (Table 2).
Characterization based on siderophore production
Eighty-six bifidobacterial strains comprising 56 isolates
and 30 culture collection strains were characterized for
their ability to produce siderophores using the CAS
assay (Additional file 1: Figure S1). Siderophore activity
(SA) was found to be widely distributed and strain
dependent among bifidobacterial strains. Percentage of
SA ranged from 3% to 89% siderophore units. To group
strains according to SA values, the following ranges wereestablished according to OD630nm measurements and
color change after mixing with the CAS dye. Three groups
were defined: strains with high SA in the range from 90-
60% siderophore units and a color change to orange;
strains with intermediate SA in the range from 59-30%
and a color change to pink, and strains with intermediate
SA in the range from 29-0% and no visible color change.
Thirty-four strains (41%) belonged to the first group of
high SA, 32 strains (36%) showed intermediate SA, and 20
strains (23%) showed low SA. No correlation was found
between SA and hemoglobin levels of the infant stool
donor where the strains were isolated (Additional file 2:
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10 strains belonged to public culture collections and 24
strains belonged to the isolates. Compare to B. bifidum
MRSc6-292, the strain with the lowest SA (3 +/−1%), eight
B. breve, five B. bifidum, three B. pseudolongum, four B.
kashiwanohense and three B. thermoacidophilum strains
showed significantly higher SA (p < 0.0001). B. breve
showed the highest SA value among species, with 76 +/−
21% (n = 12) (Figure 1a).
Strains showing similar genotypic identification in the
16S rRNA sequence, isolated from same stool sample
and plate and that also showed similar SA value; as well
as, strains showing low siderophore activity, were
excluded from the iron internalization (II) characterization.
Therefore 43 isolates and 19 culture collection strains were
available for II characterization.DNA finger printing
Phylogenetic diversity of sixty-two Bifidobacterium strains
included in the II characterization was evaluated by DNA-
finger printing using RAPD and REP-PCR (Additional
file 3: Figure S2). DNA finger prints showed that strains
retained for the II characterization were phylogenetically
different, except for B. breve TPY 10–2 and B. pseudolon-
gum BSM 8–1 as they showed identical DNA finger prints
with B. breve TPY 10–1 and B. pseudolongum BSM 8–2,
respectively.Characterization based on iron internalization
Sixty bifidobacterial strains comprising 41 isolates and
19 culture collection strains were characterized by the
iron uptake assay determined by using graphite furnace
atomic absorption spectrophotometer. Iron internalization
(II) was found to be strain dependent and B. kashiwano-
hense was the bifidobacterial species with the highest
overall iron internalization of 78 μM +/− 27 (n = 7)
(Figure 1b). Iron concentrations tested in bifidobacterial
pellets ranged from 8 μM to 118 μM (Figure 2). Eight B.
longum strains, six B. kashiwanohense, three B. bifidum,
one B. pseudolongum and one B. breve showed significantly
higher II values (p < 0.0001) than B. thermoacidophilum
LMG21397 exhibiting the lowest II of 8 μM.Figure 1 Siderophore activity (a) and iron internalization within bifidoDiscussion
In the present study, 56 bifidobacterial strains with high
iron sequestration properties were isolated from fecal
samples of iron deficient Kenyan infants, most of them
anemic, using an iron depleted culture dependent ap-
proach. We assumed for our research that in breast-fed
infants little iron enters the colon and thus low iron
availability is expected in the gut. Indeed, iron content
in breast milk was reported to be in the range from
0.4 mg/L to 0.5 mg/L [25-27]. Thus, a high competition
of strains for iron would be present in the gut of breast
fed infants, creating selective pressure for strains with
high iron sequestration properties. After the genotypic
identification the iron sequestration properties of the
isolates were measured and compared to those of culture
collection strains.
Using qPCR targeting the xfp gene, high populations
of bifidobacteria were found in fecal samples of Kenyan
infants in agreement with previous studies where popu-
lation was found to be in the range of 109-1010 gene copy
numbers per gram feces in breast fed infants [28,29]. To
perform the enrichment of bifidobacterial diversity with
high iron sequestration mechanisms a culture dependent
approach was applied, combining the low iron environ-
ment characterized from Kenyan infants, with the use of
2,2-dipiridyl which is a strong chelator for iron. The most
frequently isolated bifidobacterial species were B. bifidum,
B. longum, B. breve, B. pseudolongum and B. pseudocate-
nulatum which are species frequently found in the infant
gut [5,30]. The application of strong iron limitation during
the isolation process may have limited the growth of some
bifidobacterial species that could not grow under these
stringent conditions. On the other hand the identification
of strains from six phylogenetic taxa present in infant
stool suggest that bifidobacteria is able to efficiently over-
come iron limitation as one of the mechanisms active in
the gut.
Using culture independent methods Turroni et al. [3]
showed that a broad diversity of species were present in
the gut of European infants. Major bifidobacterial groups
identified were B. breve, B. bifidum, B. longum, B. pseu-
docatenulatum and B. pseudolongum in agreement with
our study. As shown in Table 1, the most frequentlybacterial species (b).
Figure 2 Characterization of bifidobacterial strains for siderophore activity and iron uptake measured by the CAS assay and iron
internalization test, respectively. Columns show siderophore activity (%) (n = 2) and squares show the results of iron internalization (μM)
(n = 2). Striped columns indicate selected strains after strain characterization. Error bars correspond to standard deviations calculated for two
independent replicates for iron uptake and siderophore activity respectively.
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bifidum and B. longum which are bifidobacterial species
highly encountered in breast fed infants. In addition,
using culture dependent studies, Turroni et al. [31] and
Matsuki et al. [32] showed that the most frequently iso-
lated species in fecal samples from European infants
were B. longum, B. adolescentis and B. breve, B. longum,
respectively. This is in contrast to our study where B.
animalis or B. catenulatum were not detected while B.
kashiwanohense was isolated in three fecal samples, pos-
sibly reflecting species distribution between African and
European infants, a bias resulting from the stringent iron
limitation, or a non-identified species in previous stud-
ies. B. kashiwanohense has been reported for the first
time from feces of a healthy Japanese infant in 2011 and
is known to be close to B. pseudocatenulatum and B.
catenulatum, that are species commonly found in the
infantile gut [33]. In addition, B. kashiwanohense was
only found in three samples which can be associated
with an interindividual variability in species distribution
which was previously shown for premature and term
infants [5,34,35].
Iron is an essential micronutrient for most microor-
ganisms and directly impacts the metabolism of micro-
organisms. Functions regulated by iron in bacteria are
those involved in iron utilization or acquisition and two
transport systems have been described in iron uptake
pathways [11]. Bacteria secrete iron scavenging com-
pounds, siderophores, to fulfill their iron requirement for
growth. A high fraction (41%) of bifidobacterial strainswere in the high SA group, with B. breve exhibiting the
highest siderophore activity. In addition, the major frac-
tion of the strains exhibiting high SA belonged to the
isolates from infants stool samples, which highlights
the importance of testing new isolates for this property.
Previous studies demonstrated that bifidobacterial strains
can inhibit competing organisms in an iron concentration
dependant manner [9]. However, it was also recently
reported that the growth of some bifidobacterial strains
was not affected by the presence of iron chelators such
as 2,2-dipiridyl and 8-hydroxyquinoline [36,37]. Although
different attempts have been done to identify iron seques-
tration mechanisms no study demonstrated the production
of iron scavenging compounds in culture supernatant. Pro-
duction of iron scavenging compounds is a common strat-
egy to compete in environments where iron is limited and
activation of this mechanism could represent an advantage
for bifidobacteria in the presence of competing bacteria of
the gut microbiota.
Bifidobacterial strains were characterized towards iron
internalization which is a potential mechanism to scav-
enge iron and to provide competition. Interestingly, B.
kashiwanohense showed the highest II activity suggest-
ing that B. kashiwanohense has efficient sequestration
systems that may play a role in competing for iron in
the intestine [16]. Thus, the efficient iron uptake
systems of bifidobacteria, such as production of iron
scavenging compounds and iron internalization, may
be important from the point of view of nutritional
immunity [36,37].
Table 3 Strains from culture collections used for
characterization of siderophore activity and iron
internalization
Strain Culture collection Number
Bifidobacterium adolescentis DSMZ 20083
Bifidobacterium animalis DSMZ 10140
Bifidobacterium animalis DSMZ 20105
Bifidobacterium bifidum DSMZ 20456
Bifidobacterium boum DSMZ 20432
Bifidobacterium breve DSMZ 20213
Bifidobacterium catenulatum DSMZ 16992
Bifidobacterium lactis LFB culture collection DC1
Bifidobacterium lactis LFB culture collection DC5
Bifidobacterium longum ATCC 15708
Bifidobacterium longum ATCC 51870
Bifidobacterium longum LFB culture collection DC7
Bifidobacterium longum LFB culture collection NCC2705
Bifidobacterium longum DSMZ 20088
Bifidobacterium longum DSMZ 20211
Bifidobacterium longum DSMZ 20219
Bifidobacterium pseudocatenulatum DSMZ 20438
Bifidobacterium pseudolongum DSMZ 20099
Bifidobacterium thermoacidophilum DSMZ 15837
Bifidobacterium thermoacidophilum DSMZ 17755
Bifidobacterium thermoacidophilum LMG 21395
Bifidobacterium thermoacidophilum LMG 21396
Bifidobacterium thermoacidophilum LMG 21397
Bifidobacterium thermophilum LFB culture collection RBL67
Bifidobacterium thermophilum LFB culture collection RBL68
Bifidobacterium thermophilum LFB culture collection RBL70
Bifidobacterium thermophilum DSMZ 20210
Bifidobacterium thermophilum DSMZ 20212
Bifidobacterium thermophilum LFB culture collection F9K9
Bifidobacterium spp. LFB culture collection BB46
DSMZ: German Collection of Microorganisms, ATCC: American Type Culture
Collection, LMG: Belgian co-ordinated Collections of Micro-organisms,
LFB: Laboratory of Food Biotechnology ETH Zurich culture collection.
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wanohense species were identified, standard deviation
within each species group was very high, reflecting a
remarkably strain specificity towards SA and II. Different
SA and II properties between species and strains enable
the selection of strains with the highest iron sequestra-
tion activities with possible competitive advantage when
competing in the iron limited intestine. No correlation
was found between siderophore activity and iron intern-
alization (Spearman’s correlation: −0.22) implicating that
these two properties are independently controlled, in
agreement with previously reported studies where the
two properties were not related [12,38]. In our study
sixteen out of twenty strains that showed high SA and II
are strains isolated from iron deficient infant stools. Four
strains exhibited both high SA and II characteristics: B.
pseudolongum PV8-2, B. kashiwanohense PV20-2, B.
bifidum PV28-2a, B. longum PV5-1 (Figure 2). The mech-
anisms involved in iron acquisition have been shown to
play an important role during enteric infection [39-41]. It
has been recognized that most of the dominant colonizers
of an environment have efficient iron scavenging systems
and can inhibit the growth of other competing organisms
by depriving them from iron [12]. Herein, selected strains
could be further tested for the utilization of iron seques-
tration mechanisms for host protection in complex gut
ecosystems where mechanisms involved in iron competi-
tion have been addressed to play an important role [39].
Conclusions
A wide diversity of bifidobacterial strains with high iron
sequestration properties were obtained from fecal samples
of iron deficient Kenyan infants in a culture dependent
approach targeting low iron environments. Bifidobacterial
species from public culture collections and newly isolated
strains were characterized for siderophore production in
culture supernatant and iron internalization which en-
abled the selection of four strains isolated from infant
stools with high iron sequestration mechanisms. The im-
plication of an efficient utilization of iron sequestration
mechanisms by selected bifidobacteria strains to inhibit
enteric pathogens could be further tested in complex gut
ecosystems and may uncover one of the mechanisms of
bifidobacteria for host protection against infection.
Methods
Culture collection strains
Twenty-one Bifidobacterium strains belonging to differ-
ent culture collections (DSMZ, ATCC, LMG) and nine
belonging to our own culture collection were used for
strain characterization and are listed in Table 3. Add-
itionally, 56 bifidobacterial strains typed to species level
were isolated from 28 stool samples from Kenyan infants
(Table 2).Cultivation conditions
Working cultures were obtained by inoculating strain
stocks (1% inoculation rate) maintained at −80°C in 10 mL
de Man, Rogosa and Sharpe broth (Biolife, Italy) (MRS),
pH 6.0, supplemented with 0.5 g/L L-cysteine (cys) (Sigma-
Aldrich, Switzerland). Incubation was carried out in an
anaerobic chamber (Coy Laboratory Products Inc., Inc.)
with an atmosphere of 85% N2, 10% CO2 and 5% H2
(PanGas AG, Switzerland) at 37°C for 48 h. Peptone water
(Oxoid, Switzerland) supplemented with 0.05% cys, pH 6.5
(peptone-cys) was used as a re-suspension solution. In
order to achieve iron limited conditions a chemically semi-
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iron) was used, containing: 5.64 g/L 5X M9 minimal salts,
5.0 g/L proteose-peptone (Becton Dickinson, Switzerland),
0.2 g/L cys, 20 mL/L of 20% glucose, 2 mL/L of 1 M
MgSO4 and 0.2 mL/L of 1 M CaCl2 2H2O (Sigma-Aldrich,
Switzerland). The M9 minimal salts, proteose-peptone and
cys were dissolved in 980 mL of double distilled water and
autoclaved. Glucose, magnesium and calcium were solubi-
lized in double distilled water to the desired concentration
(see above), filter-sterilized (0.22 μm pore size, Millipore,
Switzerland), and added to the autoclaved portion. For
measuring the ability to internalize iron an iron uptake so-
lution (IUS), with 0.05 μM Fe, pH 6.5 was used, containing:
0.4 g/L KCl; 8 g/L NaCl; 0.14 g/L CaCl2 2H2O; 2 g/L glu-
cose; 8.2 g/L sodium acetate (Sigma-Aldrich, Switzerland);
0.2 g/L cys was used.
Fecal samples for Bifidobacterium strains isolation
Twenty-eight baseline stool samples from Kenyan infants
(fifteen male, thirteen female) were used for Bifidobacter-
ium strain isolation [42]. Stools were obtained from eight-
een anemic and six iron deficient infants (hemoglobin level
<11 g/dL) and from four infants for whom no hemoglobin
data was available. All infants were 6 +/−0.25 months old,
vaginally delivered, breast fed, unrelated, and they did not
receive any antibiotic/probiotic treatment in the previous
three months. Stool samples of approx. 1 g of fresh fecal
material were taken up with a sterile spatula and collected
in cryo-vials containing 20% glycerol (Sigma-Aldrich,
Switzerland) and 0.05% (final volume) cys (Sigma-Aldrich,
Switzerland). The samples were frozen at −20°C until
processing for isolation. This study was approved by the
Ethics and Research Committees of the Kenyatta National
Hospital/ University of Nairobi (KNH-ERC/A/337), the
University of KwaZulu-Natal (BF121/08) and the Swiss
Federal Institute of Technology Zurich (EK 2009-N-53).
Caregivers signed an informed consent. This study is reg-
istered at clinicaltrials.gov as NCT01111864.
Characterization of fecal samples
DNA extraction and quantitative PCR (qPCR)
DNA was extracted from 250 +/− 50 mg fecal sample by
a FastDNA SPIN kit for soil (MP Biomedicals, France)
and quantification was carried out with a Nanodrop Spec-
trophotometer (ND-1000, Witec AG, Switzerland). Total
bacteria and bifidobacteria populations were detected
by qPCR with KAPA™ SYBR® FAST qPCR kit (Biolabo
Scientifics Instruments SA, Switzerland) and a 7500 Fast
Real-Time PCR System (Applied Biosystems, Switzerland).
Total bacteria were quantified using plasmid pLME21
containing the 16S rRNA gene from Escherichia coli
JM109 which was amplified with the following primers,
Eub338 F (5′-ACTCCTACGGGAGGCAGCAG-3′)
and Eub518R (5′-ATTACCGCGGCTGCTGG-3′) [22].Bifidobacterium spp. was quantified by targeting the
xylulose-5-phosphate/fructose-6-phosphatephosphoke-
tolase gene (xfp) with the following primers, xfp-fw
(5′-ATC TTCGGACCBGAYGAGAC-3′) and xfp-rv
(5′-CGATVACGTGVACGAAGGAC-3′) [43,44]. Sam-
ples were analyzed twice in a total volume of 25 μL
using KAPA™SYBR®FAST qPCR Master Mix (24 μL)
containing 1 μL template DNA diluted 1:100 and 1:10 for
total bacteria and bifidobacteria, respectively. Sample
mean gene copy numbers (CN) per gram of feces (n = 2)
were obtained from standard curves generated for each
qPCR run using serial dilutions of control standard ampli-
cons. PCR cycles consisted of initial activation at 95°C for
10 min, 40 cycles of denaturation at 95°C for 15 s, anneal-
ing at 60°C for 30 s, and elongation at 60°C for 30 s.
Strain isolation
Stool samples were streaked on Beerens agar (BRS) [45];
de Man, Rogosa and Sharpe agar (Biolife, Italy) (MRS),
supplemented with 0.5 g/L L-cysteine HCl (cys) (Sigma-
Aldrich, Switzerland), pH 6.0; Trypticase-phytone-yeast
(TPY) [46] agar and Bifidus selective agar (BSM) (Fluka,
Switzerland) [47].To enhance the isolation of bifidobac-
teria with high iron sequestration properties a strong
iron chelator, 2,2-dipyridyl (Sigma-Aldrich, Switzerland)
at 50 μM [48] was supplemented to the enrichment agar.
Incubation was carried out in the anaerobic chamber at
37°C for 48 h. Based on different morphologies three
colonies were picked per enrichment agar, streaked for
purity and cultured in MRS-cys broth. Cultures were grown
to an OD600nm (Biowave CO8000, Biochrom, England) of
1 +/− 0.5. Purity was verified microscopically and cultures
were stored at −80°C in a final concentration of 20% (vol/
vol) glycerol and 0.05% cys. Pellets obtained from liquid
cultures were stored at −20°C for DNA extraction.
Genotypic characterization
DNA was extracted from cell pellets using a Wizard
Genomic DNA purification kit (Promega AG, Switzerland)
according to the manufacturer’s instructions and strains
were typed to species level using 16S rRNA sanger se-
quencing as described by Jost et al., 2013 [49]. Briefly,
PCR amplification of 16S rRNA genes was performed
using a 4:1 mixture of forward primers 8f (5′-AGA
GTTTGATCMTGGCTC AG-3′, universal) and 8f-bif
(5′-AGGGTTCGATTCTGGCTCAG-3′, Bifidobacterium-
specific) and a universal bacterial reverse primer 1391R
(5′-GACGGGCGGTGTGTRCA-3′) (Microsynth AG,
Switzerland). PCR reaction mixture of 50 μL contained
25 μL of 2X MasterMix (Fermentas GmbH, Switzerland),
0.2 μM of each primer (−mixture) and 1 μl of template
DNA diluted to 1 ng/μL. Thermocycling (BiometraTPro-
fessional Thermocycler; Biolabo Scientific Instruments SA,
Switzerland) was performed with an initial denaturation
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carried out by thirty cycles at 94°C for 30 s, annealing
at 57°C for 60 s and extension at 72°C for 30 s with a final
extension at 72°C for 420 s. Specificity and amplicon size
were verified by electrophoresis in 1.5% (w/v) agarose gels,
and reactions were purified using an illustra GFX PCR
DNA and Gel Band Purification Kit (GE Healthcare
Europe GmbH, Switzerland) according to the manufac-
turer’s instructions. Cycle sequencing PCR was carried
out in 20 μL reaction volumes with 5% (v/v) BigDye v3.1
(Applied Biosystems Europe BV), 4 μL of 5X sequencing
buffer (Applied Biosystems, Switzerland), 1 μM of reverse
primer 1391R and 1 μL of purified PCR template. Ther-
mocycling (labcycler; SensoQuest GmbH, Switzerland)
was performed with an initial denaturation step at 96°C
for 300 s, followed by thirty-five cycles of denaturation at
96°C for 10 s, annealing at 55°C for 20 s and extension at
60°C for 240 s. Reactions were purified by dextran gel
bead filtration (Sephadex; GE Healthcare, Switzerland)
before loading 10 μL for capillary electrophoresis (ABI
3130xl DNA Analyzer; Applied Biosystems, Switzerland).
Sequencing trace chromatograms were quality-trimmed
and checked for miscalled bases using CLC Genomics
Workbench 64 v6.0.5 (CLC bio, Denmark). DNA extrac-
tion and Sanger sequencing were carried out twice from
two independent cultures. 16S rRNA partial sequences
were aligned with the Basic Local Alignment Search Tool
algorithm (BLAST) to the GenBank database and geno-
typic assignments were based on the nearest neighbor
(<97% sequence similarity).
Siderophore production
Eighty-six bifidobacteria strains from isolation and culture
collections and were tested for siderophore production in
culture supernatant by the Chroma Azurol S (CAS) assay
[15]. Cells were grown twice in 10 mL MRS-cys broth
under anaerobic conditions, centrifuged 10,000 g for
10 min at 24°C, supernatant discarded and re-suspended
in peptone-cys water. CSDLIM medium (15 mL) was
inoculated with 2% v/v of bacterial re-suspension. Strains
were cultured anaerobically to an OD600nm of 1.5 +/− 0.3
corresponding to log 6 +/− 0.3 CFU/mL. Siderophore
activity was measured in culture supernatant and calcu-
lated as percentage of siderophore units according to
Payne et al. [48]. Briefly, 2 mL of culture were centrifuged
at 10,000 g for 10 min at 4°C. 0.5 mL of cultured super-
natant was mixed with 0.5 mL of CAS dye and 0.01 mL of
shuttle solution and absorbance (As) was measured at
630 nm (OD630nm) after 6 hours. 0.5 mL of uncultured
media plus 0.5 mL of CAS dye and 0.01 mL of shuttle
solution were mixed to obtain the absorbance reference
(Ar) and uncultured CSDLIM media served as blank for
absorbance measurements. A formula was used to obtain
percentage of siderophore units: % of siderophore units =[(Ar – As)/Ar] x 100. L. casei DSMZ 20011 was used as
negative control since according to Pandey [10] sidero-
phores are not synthesized by Lactobacillus spp.. E. coli
K12 was used as positive control due to their ability to
produce siderophores in low iron environments [50].
From the starting 86 bifidobacterial strains tested isolates
showing similar (97-100%) genotypic identification in the
16 s rRNA, isolated from same stool sample and plate,
and that also show similar SA value; as well as, strains
showing low siderophore activity, were excluded for the
iron uptake (II) assay.
DNA finger printing
Phylogenetic diversity of sixty-two Bifidobacterium strains
included in the II, was evaluated by DNA-finger printing
using RAPD and REP-PCR. RAPD reactions were per-
formed according to Jost et al. [51]. RAPD amplification
reactions consisted of 25 μL that contained 12.5 μL of 2X
Master Mix (Fermentas, Switzerland), 1 μM of primer
(100 μM) (Mycrosynth, Switzerland) and 1 μL of DNA
template diluted to approximately 50 ng/μL. Four separate
RAPD reactions were performed for each species, using
primers OPA-02 (5′-TGCCGAGCTG-3′), OPL-07 (5′-G
GGAACGTGT-3′), OPL-16 (5′-GGGAACGTGT-3′) and
OPA-13 (5′- CAGCACCCAC-3′). For reactions using
primers OPA-02, OPL-07, OPL-13 and OPL-16, thermo-
cycling was performed with an initial denaturation step at
95°C for 3 min, followed by 45 cycles of denaturation at
94°C for 1 min, annealing at 30°C for 1 min and extension
at 72°C for 2 min. Due to the limited number of bands
identified in B. kashiwanohense and B. pseudolongum spe-
cies, REP-PCR was performed as described previously [52].
REP-PCR was performed using the primer REP1R-I (5′-
NNNNCGNCGNCATCNGGC-3′) and REP2-I (5′-NC
GNCTTATCNGGCCTAC-3′) (Mycrosynth, Switzerland).
REP-PCR reactions were carried out with an initial denatur-
ation step at 95°C for 3 min, followed by 30 cycles at 90°C
for 30 s, 40°C for 1 min and 72°C for 1.5 min, and final ex-
tension at 72°C for 8 min. RAPD and REP-PCR products
were visualized by UV light on ethidium bromide stained
agarose (1.5%) after gel electrophoresis in 1 ×TAE-buffer
(pH 8.0), using 1-kb ladder (Fermentas GmbH, Switzerland)
as reference.
Characterization based on iron internalization
Sixty strains, 41 isolates and 19 strains belonging to
culture collections, were characterized for iron uptake
characterization. For iron internalization the method
described by Kot et al. [53] was used with some modifi-
cations. Briefly, Bifidobacterium strains were grown twice
under anaerobic conditions in MRS-cys broth for 24 h at
37°C. Cultures were centrifuged 10,000 g (Biofuge primo,
Heraeus, Switzerland) at 24°C, 10 min and supernatant
discarded. A cell suspension was prepared with OD600nm
Vazquez-Gutierrez et al. BMC Microbiology  (2015) 15:3 Page 9 of 10adjusted to 1 with peptone-cys water. This suspension was
used to inoculate 25 mL of CSDLIM medium at 2% v/v
and cultured to an OD600nm of 1 +/− 0.25. Culture was
centrifuged and supernatant discarded, and cells were re-
suspended in 10 mL volume of the iron uptake solution
(IUS) to yield a concentration of log 8+/− 0.3 CFU/mL.
Two tubes of same volume containing the standardized
culture were prepared to determine the amount of iron in-
ternalization. The first tube without added iron served as
the reference for the original amount of iron present in
the pellet. The second tube was supplemented with
35 μM FeSO4 freshly prepared and was used to measure
the amount of internalized iron. Both tubes were incu-
bated for 60 min at 37°C under anaerobic conditions, then
placed immediately on ice, centrifuged 15 min at 10,000 g
(Biofuge primo, Heraeus), and washed twice with 2 mL
sterile double distilled water. All samples were processed
in duplicate. Iron concentration in the pellet (μM) was
measured by graphite furnace atomic absorption spectro-
photometer (AA-240Z, Varian Inc., Australia) according
to manufacturer’s instructions. Briefly, pellet was mixed
with, 0.5 mL of nitric acid 65% added with 0.5 mL of ultra-
pure water (Super-Q® plus, Millipore, Switzerland), soni-
cated for 30 min at room temperature, and centrifuged
5 min, 10,000 g. Supernatants were diluted with ultrapure
water to adequate iron concentration. Standard curves
were generated by serial dilution of a commercial iron
standard solution (Titrisol, Merck Chemicals, Germany).
Statistical analysis
Data from two independent trials were analyzed by com-
paring the means with the nonparametric, multiple com-
parisons with control, Dunnett’s method. For statistical
analysis of siderophore activity, B. bifidum MRSc6-292
served as control strain with the lowest siderophore
activity and was compared to the rest of the strains. Con-
trol sample for statistical analysis of iron internalization
was B. thermoacidophilum LMG21397 with the lowest
iron internalization value. Correlation between the two set
of data was assessed by Spearman’s correlation.
Nucleotide accession numbers
The main nucleotide sequences determined in this
study have been assigned GenBank Accession numbers:
[GenBank: KJ412975-KJ412985].
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